引用本文:王洪江,陈永昕.miRNAs与乳腺癌关系的研究进展[J].大连医科大学学报,2011,33(2):178-181+191.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 次   下载 本文二维码信息
码上扫一扫!
分享到: 微信 更多
miRNAs与乳腺癌关系的研究进展
王洪江1, 陈永昕2
1.大连医科大学 附属第一医院 普外科,辽宁 大连 116011;2.The Surgery of the University of Texas Health Science Center,San Antonio 78229,USA
摘要:
微小RNA(miRNAs)是一类内源性非编码小分子RNA,在细胞增殖、分化、凋亡,代谢等多种生物学过程中都起到重要作用。miRNAs在乳腺癌中表达上调,可促进乳腺癌的发生、发展。循环miRNAs检测可能成为诊断乳腺癌的无创的、有效的生物标记物,而且miRNAs与一些抗肿瘤药物敏感性相关,使其可能成为具有潜力的治疗靶点。
关键词:  miRNAs  乳腺肿瘤  诊断  进展
DOI:10.11724/jdmu.2011.02.20
分类号:R737.9
基金项目:
Development of research on the relationship between miRNAs and breast cancer
WANG Hong-jiang1, CHEN Yong-xin2
1.Department of General Surgery, the First Affiliated Hospital of Dalian Medical Universiy, Dalian 116011, China;2.The Surgery of the University of Texas Health Science Center,San Antonio, Texas 78229,USA
Abstract:
miRNAs are endogenous, non-coding small RNAs that play an important role in the many biological processes including cell proliferation, differentiation, apoptosis and ontogeny.miRNAs can promote the occurrence and advance of the breast cancer by upregulation the expression of miRNAs in breast cancer. Detection of circulating miRNAs may become non-invasive, effective biomarkers to diagnose the breast cancer. miRNAs also related to the sensitivity to anticancer drugs, and miRNAs would become a potential therapeutic target of the breast cancer.
Key words:  miRNAs  mammary carcinoma  diagnosis  development